Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model

被引:55
作者
Keramidas, M. [2 ]
Josserand, V. [2 ]
Righini, C. A. [2 ,3 ]
Wenk, C. [2 ]
Faure, C. [2 ,3 ]
Coll, J. L. [1 ,2 ]
机构
[1] Inst Albert Bonniot, Inst Natl Sante & Rech Med, U823, Equipe 5, F-38042 Grenoble 9, France
[2] Univ Grenoble 1, Grenoble, France
[3] Univ Hosp Grenoble, Grenoble, France
关键词
ALPHA-V-BETA-3; INTEGRIN; CANCER; ALPHA(V)BETA(3); MULTIVALENT; EXPRESSION; MICE;
D O I
10.1002/bjs.6986
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: This study compared the quality of surgery performed under conventional light with near-infrared (NTR) image-guided surgery using a tumour-targeting probe and a portable clinical grade imaging device in a mouse model of peritoneal carcinomatosis. Methods: Peritoneal carcinomatosis was induced by injection of luciferase-positive tumour cells, leading. to the formation of small nodules in the peritoneal cavity. One day after intravenous injection of RAFT-c(RGDfK)(4)-Alexa Fluor 700 (R), a fluorescent tumour-targeting probe, the surgeon operated using the Fluobeam (R), a portable device that illuminated the mouse with NIR light and allowed NIR vision. The quality of the surgery was evaluated using bioluminescence, a highly sensitive method that detected the remaining tumour cells, and operating time was measured. Results: Under normal light, the surgeon detected and removed a mean(s.d.) of only 50.6(2.3) per cent of the nodules that were visible under NTR light. The duration of surgery was reduced from 19.5(3.3) min under normal light to 14.0(2.6) min when NIR light was used (P = 0.025). The sensitivity of the NIR system allowed the detection of nodules containing as few as 227 tumour cells. Conclusion: NI R image-guided surgery improved the quality of surgery for peritoneal carcinomatosis by doubling the number of nodules detected and significantly reducing the duration of surgery.
引用
收藏
页码:737 / 743
页数:7
相关论文
共 21 条
[1]
Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis [J].
Boturyn, D ;
Coll, JL ;
Garanger, E ;
Favrot, MC ;
Dumy, P .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (18) :5730-5739
[2]
Integrin αVβ3-targeted imaging of lung cancer [J].
Chen, XY ;
Sievers, E ;
Hou, YP ;
Park, R ;
Tohme, M ;
Bart, R ;
Bremner, R ;
Bading, JR ;
Conti, PS .
NEOPLASIA, 2005, 7 (03) :271-279
[3]
Synthesis and Biological Characterisation of Targeted Pro-Apoptotic Peptide [J].
Foillard, Stephanie ;
Jin, Zhao-Hui ;
Garanger, Elisabeth ;
Boturyn, Didier ;
Favrot, Marie-Christine ;
Coll, Jean-Luc ;
Dumy, Pascal .
CHEMBIOCHEM, 2008, 9 (14) :2326-2332
[4]
New technologies for human cancer imaging [J].
Frangioni, John V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :4012-4021
[5]
Multivalent RGD synthetic peptides as potent αVβ3 integrin ligands [J].
Garanger, E ;
Boturyn, D ;
Coll, JL ;
Favrot, MC ;
Dumy, P .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (10) :1958-1965
[6]
New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors [J].
Garanger, E ;
Boturyn, D ;
Jin, ZH ;
Dumy, P ;
Favrot, MC ;
Coll, JL .
MOLECULAR THERAPY, 2005, 12 (06) :1168-1175
[7]
INTEGRIN EXPRESSION IN HUMAN-MELANOMA CELLS WITH DIFFERING INVASIVE AND METASTATIC PROPERTIES [J].
GEHLSEN, KR ;
DAVIS, GE ;
SRIRAMARAO, P .
CLINICAL & EXPERIMENTAL METASTASIS, 1992, 10 (02) :111-120
[8]
GLIOBLASTOMA EXPRESSION OF VITRONECTIN AND THE ALPHA-V-BETA-3 INTEGRIN - ADHESION MECHANISM FOR TRANSFORMED GLIAL-CELLS [J].
GLADSON, CL ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1924-1932
[9]
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study [J].
Glehen, O ;
Kwiatkowski, F ;
Sugarbaker, PH ;
Elias, D ;
Levine, EA ;
De Simone, M ;
Barone, R ;
Yonemura, Y ;
Cavaliere, F ;
Quenet, F ;
Gutman, M ;
Tentes, AAK ;
Lorimier, G ;
Bernard, JL ;
Bereder, JM ;
Porcheron, J ;
Gomez-Portilla, A ;
Shen, P ;
Deraco, M ;
Rat, P ;
Gilly, FN .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3284-3292
[10]
Gutowski M, 2001, CLIN CANCER RES, V7, P1142